Zivo Bioscience Stock Current Valuation
Valuation analysis of Zivo Bioscience helps investors to measure Zivo Bioscience's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Zivo Bioscience Company Current Valuation Analysis
Zivo Bioscience's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zivo Bioscience Current Valuation | 2.02 M |
Most of Zivo Bioscience's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zivo Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Zivo Bioscience has a Current Valuation of 2.02 M. This is 99.99% lower than that of the Personal Care Products sector and 99.96% lower than that of the Consumer Staples industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Zivo Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zivo Bioscience's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics of similar companies.Zivo Bioscience is currently under evaluation in current valuation category among its peers.
Zivo Fundamentals
| Return On Equity | -39.56 | ||||
| Return On Asset | -1.65 | ||||
| Operating Margin | (133.25) % | ||||
| Current Valuation | 2.02 M | ||||
| Shares Outstanding | 1.82 M | ||||
| Shares Owned By Insiders | 25.23 % | ||||
| Shares Owned By Institutions | 4.44 % | ||||
| Number Of Shares Shorted | 35.47 K | ||||
| Price To Earning | (1.95) X | ||||
| Price To Book | 17.86 X | ||||
| Price To Sales | 2,639 X | ||||
| Gross Profit | 20 K | ||||
| EBITDA | (8.73 M) | ||||
| Net Income | (8.75 M) | ||||
| Cash And Equivalents | 5.08 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 445.18 K | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 2.08 X | ||||
| Book Value Per Share | (0.63) X | ||||
| Cash Flow From Operations | (7.1 M) | ||||
| Short Ratio | 6.65 X | ||||
| Earnings Per Share | (5.33) X | ||||
| Target Price | 36.0 | ||||
| Beta | 0.27 | ||||
| Market Capitalization | 2 M | ||||
| Total Asset | 2.12 M | ||||
| Retained Earnings | (115.8 M) | ||||
| Working Capital | (126.04 K) | ||||
| Current Asset | 28.93 K | ||||
| Current Liabilities | 4.97 M | ||||
| Z Score | -87.31 | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 2.12 M |
Pair Trading with Zivo Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zivo Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Equifax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Equifax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Equifax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Equifax to buy it.
The correlation of Equifax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Equifax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Equifax moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Equifax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets |